COMPANY OVERVIEW

Turnstone Biologics is a leading next-generation immuno-oncology company driven by science with experienced leadership and world-renowned scientific founders focused on bringing novel oncolytic viral immunotherapies to patients

---

LOCATION

Ottawa, Ontario, Canada

New York, NY, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://www.turnstonebio.com/

---

CAREER WEBSITE

https://www.turnstonebio.com/#

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jul 21, 2023

Turnstone Biologics Corp. Announces Pricing of Upsized Initial Public Offering

Apr 13, 2023

Turnstone Biologics to Present Preclinical Data for Selected TIL Therapy at the 2023 American Association for Cancer Research (AACR) Annual Meeting

Nov 29, 2022

Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute to Study TIL Therapy in Combination with Viral Immunotherapy

Nov 29, 2022

Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute to Study TIL Therapy in Combination with Viral Immunotherapy

Nov 8, 2022

Turnstone Biologics to Present Preclinical Data From Novel TIL Therapy Demonstrating Tumor-Reactive T-Cell Selection at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

For More Press Releases

---